CVRx (CVRX) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.30, -6.47% vs the prior close of $1.39.
- Volume 382.71K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CVRX slides 6.5% to $1.30, a 52-week low. Closed at $1.30, -6.47% vs the prior close of $1.39. Day range $1.25–$1.39, opened at $1.39.
CVRX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CVRX slides 6.5% to $1.30, a 52-week low
- Closed at $1.30, -6.47% vs the prior close of $1.39. Day range $1.25–$1.39, opened at $1.39.
- Volume was 382.71K shares, 0.3x its 50-day average of 1.15M — lighter than usual.
- Price is -48.6% vs its 50-day average ($2.53) and -76.7% vs its 200-day average ($5.58).
- 52-week range $1.25–$11.30; today's close sits at 0% of that range, 88.5% below the 52-week high.
Oct 15, 2026 — CVRX jumps 3.7% to $1.39
- Closed at $1.39, +3.73% vs the prior close of $1.34. Day range $1.33–$1.44, opened at $1.36.
- Volume was 360.70K shares, 0.3x its 50-day average of 1.15M — lighter than usual.
- Price is -47.0% vs its 50-day average ($2.62) and -75.2% vs its 200-day average ($5.61).
- 52-week range $1.28–$11.30; today's close sits at 1% of that range, 87.7% below the 52-week high.
Oct 14, 2026 — CVRX dips 1.5% to $1.34, a 52-week low, 4 down days in a row
- Closed at $1.34, -1.47% vs the prior close of $1.36. Day range $1.28–$1.40, opened at $1.33.
- Volume was 893.20K shares, 0.8x its 50-day average of 1.13M.
- Price is -50.5% vs its 50-day average ($2.70) and -76.3% vs its 200-day average ($5.64).
- 52-week range $1.28–$11.30; today's close sits at 1% of that range, 88.1% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — CVRX slides 8.1% to $1.36, a 52-week low, 3 down days in a row
- Closed at $1.36, -8.11% vs the prior close of $1.48. Day range $1.35–$1.49, opened at $1.49.
- Volume was 489.80K shares, 0.4x its 50-day average of 1.12M — lighter than usual.
- Price is -51.2% vs its 50-day average ($2.79) and -76.0% vs its 200-day average ($5.67).
- 52-week range $1.35–$11.30; today's close sits at 0% of that range, 88.0% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — CVRX slides 6.3% to $1.48, a 52-week low
- Closed at $1.48, -6.33% vs the prior close of $1.58. Day range $1.47–$1.66, opened at $1.58.
- Volume was 470.10K shares, 0.4x its 50-day average of 1.12M — lighter than usual.
- Price is -48.4% vs its 50-day average ($2.87) and -74.1% vs its 200-day average ($5.70).
- 52-week range $1.47–$11.30; today's close sits at 0% of that range, 86.9% below the 52-week high.
Oct 9, 2026 — CVRX slides 6.0% to $1.58
- Closed at $1.58, -5.95% vs the prior close of $1.68. Day range $1.56–$1.68, opened at $1.66.
- Volume was 398.70K shares, 0.4x its 50-day average of 1.11M — lighter than usual.
- Price is -46.3% vs its 50-day average ($2.94) and -72.5% vs its 200-day average ($5.74).
- 52-week range $1.50–$11.30; today's close sits at 1% of that range, 86.0% below the 52-week high.
Oct 8, 2026 — CVRX rises 0.6% to $1.68, 5 up days in a row
- Closed at $1.68, +0.60% vs the prior close of $1.67. Day range $1.55–$1.68, opened at $1.64.
- Volume was 519.20K shares, 0.5x its 50-day average of 1.11M — lighter than usual.
- Price is -44.4% vs its 50-day average ($3.02) and -70.9% vs its 200-day average ($5.77).
- 52-week range $1.50–$11.30; today's close sits at 2% of that range, 85.1% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — CVRX jumps 3.1% to $1.67, 4 up days in a row
- Closed at $1.67, +3.09% vs the prior close of $1.62. Day range $1.62–$1.76, opened at $1.62.
- Volume was 896.60K shares, 0.8x its 50-day average of 1.09M.
- Price is -45.9% vs its 50-day average ($3.09) and -71.2% vs its 200-day average ($5.80).
- 52-week range $1.50–$11.30; today's close sits at 2% of that range, 85.2% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — CVRX jumps 3.8% to $1.62, 3 up days in a row
- Closed at $1.62, +3.85% vs the prior close of $1.56. Day range $1.54–$1.69, opened at $1.54.
- Volume was 537.10K shares, 0.5x its 50-day average of 1.09M — lighter than usual.
- Price is -48.6% vs its 50-day average ($3.15) and -72.2% vs its 200-day average ($5.83).
- 52-week range $1.50–$11.30; today's close sits at 1% of that range, 85.7% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — CVRX rises 0.6% to $1.56
- Closed at $1.56, +0.65% vs the prior close of $1.55. Day range $1.50–$1.62, opened at $1.57.
- Volume was 576.60K shares, 0.5x its 50-day average of 1.08M — lighter than usual.
- Price is -51.5% vs its 50-day average ($3.22) and -73.4% vs its 200-day average ($5.86).
- 52-week range $1.50–$11.30; today's close sits at 1% of that range, 86.2% below the 52-week high.
Oct 2, 2026 — CVRX rises 1.3% to $1.55
- Closed at $1.55, +1.31% vs the prior close of $1.53. Day range $1.51–$1.66, opened at $1.58.
- Volume was 1.06M shares, 1.0x its 50-day average of 1.06M.
- Price is -52.8% vs its 50-day average ($3.28) and -73.7% vs its 200-day average ($5.90).
- 52-week range $1.50–$11.30; today's close sits at 1% of that range, 86.3% below the 52-week high.
CVRX latest news & SEC filings
Every SEC filing by or about CVRX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 24, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Binkowski Brent bought 26,223 shares at $2.91 (≈$76.31K) on Aug 13, 2026
- Binkowski Brent bought 26,223 shares at $2.91 (≈$76.31K) on Aug 13, 2026
- Binkowski Brent bought 26,223 shares at $2.91 (≈$76.31K) on Aug 13, 2026
- Binkowski Brent bought 26,223 shares at $2.91 (≈$76.31K) on Aug 13, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Binkowski Brent sold 1,309 shares at $2.55 (≈$3.34K) on Aug 12, 2026
- Binkowski Brent sold 1,309 shares at $2.55 (≈$3.34K) on Aug 12, 2026
- Binkowski Brent sold 1,309 shares at $2.55 (≈$3.34K) on Aug 12, 2026
- Binkowski Brent sold 1,309 shares at $2.55 (≈$3.34K) on Aug 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $15.71M (prior year $13.59M) (+15.6% vs Jun 30, 2025)
- Net income: -$14.04M (prior year -$14.74M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.53 (prior year -$0.57) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade CVRX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Apr 13, 2026, Feb 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.89% (largest 33.5%). That is a volatile stock.
- Liquidity: about 783.54K shares (≈$1.02M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.30 vs a range of $1.25–$11.30 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Brent Binkowski bought 26,223 shares on Aug 13, 2026.
- Latest filings: 8-K Sep 21, 2026; 8-K Aug 11, 2026; 10-Q Aug 6, 2026.
- Share count: 26.64M shares outstanding (Jul 30, 2026), +1.9% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
CVRX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.39 | 1.39 | 1.25 | 1.30 | 382.71K |
| Oct 15, 2026 | 1.36 | 1.44 | 1.33 | 1.39 | 360.70K |
| Oct 14, 2026 | 1.33 | 1.40 | 1.28 | 1.34 | 893.20K |
| Oct 13, 2026 | 1.49 | 1.49 | 1.35 | 1.36 | 489.80K |
| Oct 12, 2026 | 1.58 | 1.66 | 1.47 | 1.48 | 470.10K |
| Oct 9, 2026 | 1.66 | 1.68 | 1.56 | 1.58 | 398.70K |
| Oct 8, 2026 | 1.64 | 1.68 | 1.55 | 1.68 | 519.20K |
| Oct 7, 2026 | 1.62 | 1.76 | 1.62 | 1.67 | 896.60K |
| Oct 6, 2026 | 1.54 | 1.69 | 1.54 | 1.62 | 537.10K |
| Oct 5, 2026 | 1.57 | 1.62 | 1.50 | 1.56 | 576.60K |
| Oct 2, 2026 | 1.58 | 1.66 | 1.51 | 1.55 | 1.06M |
| Oct 1, 2026 | 1.75 | 1.79 | 1.50 | 1.53 | 1.46M |
| Sep 30, 2026 | 2.63 | 2.65 | 1.65 | 1.75 | 4.27M |
| Sep 29, 2026 | 2.60 | 2.76 | 2.53 | 2.63 | 373.40K |
| Sep 28, 2026 | 2.69 | 2.79 | 2.53 | 2.59 | 382.00K |
| Sep 25, 2026 | 2.56 | 2.70 | 2.51 | 2.70 | 461.60K |
| Sep 24, 2026 | 2.73 | 2.73 | 2.51 | 2.53 | 693.70K |
| Sep 23, 2026 | 2.89 | 2.89 | 2.70 | 2.72 | 481.70K |
| Sep 22, 2026 | 2.95 | 3.07 | 2.86 | 2.89 | 666.20K |
| Sep 21, 2026 | 3.03 | 3.06 | 2.91 | 2.97 | 289.10K |
About CVRx
CVRx (CVRX) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MINNEAPOLIS, MN. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1235912.
CVRX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kevin J. Ballinger | Director | Jun 3, 2026 |
| Michael D Dale | Director | Jun 3, 2026 |
| Mitch C. Hill, | Director | Jun 3, 2026 |
| Kevin Hykes | PRES & CEO | Mar 3, 2026 |
| Mudit K. Jain | Director | Jun 3, 2026 |
| Kirk G. Nielsen | Director | Jun 3, 2026 |
| Martha Shadan | Director | Jun 3, 2026 |
| Joseph P Slattery | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Philip B. Adamson | Chief Medical Officer | Mar 16, 2026 |
| Brent Binkowski | CHIEF OPERATING OFFICER | Aug 13, 2026 |
| Kevin Hykes | PRES & CEO | Mar 3, 2026 |
| Robert Allen John | Chief Revenue Officer | Mar 3, 2026 |
| Gregory Morrison | CHIEF HUMAN RESOURCES OFFICER | Mar 4, 2026 |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | Mar 3, 2026 |
| Paul Verrastro | CHIEF MKTG & STRAT OFFICER | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Brent Binkowski | Buy | 26,223 | $2.91 |
| Aug 13, 2026 | Brent Binkowski | Buy | 26,223 | $2.91 |
| Aug 13, 2026 | Brent Binkowski | Buy | 26,223 | $2.91 |
| Aug 13, 2026 | Brent Binkowski | Buy | 26,223 | $2.91 |
| Aug 12, 2026 | Brent Binkowski | Sale | 1,309 | $2.55 |
| Aug 12, 2026 | Brent Binkowski | Sale | 1,309 | $2.55 |
| Aug 12, 2026 | Brent Binkowski | Sale | 1,309 | $2.55 |
| Aug 12, 2026 | Brent Binkowski | Sale | 1,309 | $2.55 |
| Mar 2, 2026 | Philip B. Adamson | Sale | 1,262 | $7.90 |
| Mar 2, 2026 | Philip B. Adamson | Sale | 1,262 | $7.90 |
| Mar 2, 2026 | Philip B. Adamson | Sale | 1,262 | $7.90 |
| Mar 2, 2026 | Philip B. Adamson | Sale | 1,262 | $7.90 |
| Mar 2, 2026 | Paul Verrastro | Sale | 1,284 | $7.90 |
| Mar 2, 2026 | Paul Verrastro | Sale | 1,284 | $7.90 |
| Mar 2, 2026 | Paul Verrastro | Sale | 1,284 | $7.90 |
CVRX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $56.65M | $-53.31M | -2.04 | $-40.17M |
| Dec 31, 2024 | $51.29M | $-59.97M | -2.65 | $-39.14M |
| Dec 31, 2023 | $39.30M | $-41.20M | -1.99 | $-39.02M |
| Dec 31, 2022 | $22.47M | $-41.43M | -2.02 | $-42.68M |
| Dec 31, 2021 | $13.04M | $-43.08M | -4.16 | $-27.73M |
Latest balance sheet: total assets $92.28M, total liabilities $72.33M, cash $64.59M (as of Jun 30, 2026).
CVRX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $5.94 |
| May 11, 2026 | 8-K Item 2.02 (results) | $6.92 |
| Apr 13, 2026 | 8-K Item 2.02 (results) | $7.81 |
| Feb 12, 2026 | 8-K Item 2.02 (results) | $5.69 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $7.31 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $9.79 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $7.55 |
| May 8, 2025 | 8-K Item 2.02 (results) | $7.78 |
| Apr 7, 2025 | 8-K Item 2.02 (results) | $11.54 |
| Feb 4, 2025 | 8-K Item 2.02 (results) | $16.25 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $15.04 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $10.74 |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CVRX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.